(HealthDay News) – Introduction of a standardized sterile collection process for blood cultures can reduce peripheral blood culture contamination rates and hospital charges, according to ...

SEATTLE, Aug. 30, 2018 /PRNewswire/ -- Magnolia Medical Technologies today announced the successful national launch and adoption of Steripath® Gen2. The next generation Initial Specimen Diversion ...

SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the United States Patent Office allowed its ...

She will discuss the importance of a multi-disciplinary approach along with the application of an evidence-based blood culture collection bundle that has been proven to ... best practices that achieve ...

Scientists develop 'suspended animation' technique for blood draws to aid research ... RNA is particularly finicky—the Allen Institute team found that just six hours after blood collection, ...

Increasing healthcare investments, growing prevalence of chronic diseases, and advancements in blood collection technologies fuels market growth.Austin, March 17, 2025 (GLOBE NEWSWIRE) -- Blood ...

Magnolia Medical Technologies, Inc. inventors of the initial specimen diversion technique (ISDT™) and the Steripath® Initial Specimen Diversion Device® (ISDD®) for blood culture collection ...

Recently published University of Arkansas study examined the patient-specific risk factors and clinical outcomes associated with contaminated blood cultures for patients with suspected bloodstream ...

Vials used for blood culture samples are in critically low supply. Why it matters: The shortage of blood culture bottles made by Becton Dickinson (BD) could delay patients' diagnoses or lead to ...

Market Overview. The Blood Culture Pathology Tests Market is a crucial segment of the healthcare industry, dedicated to the accurate identification of pathogens responsible for bloodstream infections.